Literature DB >> 17442597

The transcription factor GABP is a critical regulator of B lymphocyte development.

Hai-Hui Xue1, Julie Bollenbacher-Reilley, Zheng Wu, Rosanne Spolski, Xuefang Jing, Yi-Chen Zhang, J Philip McCoy, Warren J Leonard.   

Abstract

GA binding protein (GABP) is a ubiquitously expressed Ets-family transcription factor that critically regulates the expression of the interleukin-7 receptor alpha chain (IL-7Ralpha) in T cells, whereas it is dispensable for IL-7Ralpha expression in fetal liver B cells. Here we showed that deficiency of GABPalpha, the DNA-binding subunit of GABP, resulted in profoundly defective B cell development and a compromised humoral immune response, in addition to thymic developmental defects. Furthermore, the expression of Pax5 and Pax5 target genes such as Cd79a was greatly diminished in GABPalpha-deficient B cell progenitors, pro-B, and mature B cells. GABP could bind to the regulatory regions of Pax5 and Cd79a in vivo. Thus, GABP is a key regulator of B cell development, maturation, and function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442597     DOI: 10.1016/j.immuni.2007.03.010

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  30 in total

1.  GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem/progenitor cells.

Authors:  Shuyang Yu; Kairong Cui; Raja Jothi; Dong-Mei Zhao; Xuefang Jing; Keji Zhao; Hai-Hui Xue
Journal:  Blood       Date:  2010-12-07       Impact factor: 22.113

2.  Identification and structural characterization of a CBP/p300-binding domain from the ETS family transcription factor GABP alpha.

Authors:  Hyun-Seo Kang; Mary L Nelson; Cameron D Mackereth; Manuela Schärpf; Barbara J Graves; Lawrence P McIntosh
Journal:  J Mol Biol       Date:  2008-01-30       Impact factor: 5.469

3.  GABPbeta2 is dispensible for normal lymphocyte development but moderately affects B cell responses.

Authors:  Xuefang Jing; Dong-Mei Zhao; Thomas J Waldschmidt; Hai-Hui Xue
Journal:  J Biol Chem       Date:  2008-07-15       Impact factor: 5.157

4.  Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice.

Authors:  Nicolas Leuenberger; Sylvain Pradervand; Walter Wahli
Journal:  J Clin Invest       Date:  2009-10       Impact factor: 14.808

5.  A strong promoter activity of pre-B cell stage-specific Crlz1 gene is caused by one distal LEF-1 and multiple proximal Ets sites.

Authors:  Sung-Kyun Park; Youngsook Son; Chang-Joong Kang
Journal:  Mol Cells       Date:  2011-05-02       Impact factor: 5.034

6.  Quantifying deleterious effects of regulatory variants.

Authors:  Shan Li; Roberto Vera Alvarez; Roded Sharan; David Landsman; Ivan Ovcharenko
Journal:  Nucleic Acids Res       Date:  2017-03-17       Impact factor: 16.971

7.  Integrated genetic approaches identify the molecular mechanisms of Sox4 in early B-cell development: intricate roles for RAG1/2 and CK1ε.

Authors:  Saradhi Mallampati; Baohua Sun; Yue Lu; Haiqing Ma; Yun Gong; Donghai Wang; Ju-Seog Lee; Kevin Lin; Xiaoping Sun
Journal:  Blood       Date:  2014-04-30       Impact factor: 22.113

8.  SAGA and ATAC histone acetyl transferase complexes regulate distinct sets of genes and ATAC defines a class of p300-independent enhancers.

Authors:  Arnaud R Krebs; Krishanpal Karmodiya; Marianne Lindahl-Allen; Kevin Struhl; Làszlò Tora
Journal:  Mol Cell       Date:  2011-11-04       Impact factor: 17.970

9.  Highly cooperative recruitment of Ets-1 and release of autoinhibition by Pax5.

Authors:  Daniel Fitzsimmons; Kara Lukin; Ryan Lutz; Colin W Garvie; Cynthia Wolberger; James Hagman
Journal:  J Mol Biol       Date:  2009-07-17       Impact factor: 5.469

10.  CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia.

Authors:  Sara González-García; Marina García-Peydró; Enrique Martín-Gayo; Esteban Ballestar; Manel Esteller; Rafael Bornstein; José Luis de la Pompa; Adolfo A Ferrando; María L Toribio
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.